Professor Allyson Pollock
- Email: firstname.lastname@example.org
- Personal Website: http://www.allysonpollock.com
- Address: Institute of Health and Society
Newcastle upon Tyne
Personal assistant: email@example.com +44(0)191 208 5593
I joined the Institute of Health & Society as Director in January 2017, having formerly been professor of public health research and policy at Queen Mary, University of London. I set up and directed the Centre for International Public Health Policy at the University of Edinburgh from 2005 to 2011, and prior to this I was head of the Public Health Policy Unit at UCL and Director of Research & Development at UCL Hospitals NHS Trust.
I trained in medicine in Scotland and became a consultant in public health medicine in 1991. My research interests include globalisation; privatisation, marketisation and PFI / PPPs; health services; regulation and trade; pharmaceuticals and clinical trials; and childhood injuries; sport; injury; concussion; head injuries; rugby; long term care; social care.
I undertake research and teaching intended to assist the realisation of the principles of social justice and public health, looking in particular at health systems research, trade, and pharmaceuticals. A strong emphasis is on developing critical analysis through education and research and through translating research findings into policy at the national and international level. The work is multidisciplinary, including epidemiology, law, statistics, economics, accounting, sociology, and anthropology.
Universal access to health care is the primary focus and in particular the means by which local and national systems redistribute resources across society by sharing the risks and costs of ill-health. My work includes the study of public private partnerships in health and long term care, pharmaceuticals, and medical research, and how public health interfaces with trade law and intellectual property agreements.
Local and global issues converge around, for instance, the social and economic aspects of clinical trials, how medicines are accessed, the estimation of the global burden of disease, and evidence underpinning access to medicines policies; the setting of health care priorities through the creation and use of clinical evidence; and the export of managed health care systems.
Other areas of research include the epidemiology of sports injury and childhood injuries and improving long term care.
I am introducing in the Institute of Health & Society teaching on global health drawing on our huge range of disciplines and research and our collective experience of and commitment to high level teaching. Future programmes may include pharmaceutical regulation and access to medicines, and sports exercise and injury.
I have established significant and influential teaching programmes in global health (MSc, BSc, and intercalated) at the University of Edinburgh and Queen Mary University of London, including the UK’s first programmes on global health systems and global health and law.
I contribute teaching on public health and health systems to Newcastle's MBBS.
- Evans V, Roderick P, Pollock AM. Adequacy of clinical trial evidence of fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. Journal of Global Health 2018, 3(2), e000263.
- Sutaria S, Roderick P, Pollock AM. Are radical changes to health and social care paving the way for fewer services and new user charges?. BMJ 2017, 358, j4279.
- Roderick P, Pollock AM. Brexit’s Great Repeal Bill will axe the right to health. BMJ 2017, 357, j2013.
- Casla K, Roderick P, Pollock AM. Disclosure of patients' data to the UK Home Office must stop. BMJ 2017, 358, j3613.
- Pollock AM, White AJ, Kirkwood G. Evidence in support of the call to ban the tackle and harmful contact in school rugby: a response to World Rugby. British Journal of Sports Medicine 2017, 51, 1113-1117.
- Pollock AM, Roderick P. Jeremy Hunt must consult properly on accountable care organisations. BMJ 2017, 359, j5349.
- Harrington C, Jacobsen FF, Panos J, Pollock AM, Sutaria S, Szebehely M. Marketisation in long term care: a cross country comparison of large for-profit nursing home chains. Health Services Insights 2017, 10, 1178632917710533.
- Pollock AM, Kirkwood G. Tackle and scrum should be banned in school rugby. BMJ 2017.
- Millard C, Kadam A, Mahajan R, Pollock AM, Brhlikova P. Availability of brands of six essential medicines in 124 pharmacies in Maharashtra. Journal of Global Health 2018, 8(1), 010402.
- Kirkwood G, Hughes TC, Pollock AM. Unintentional injury in England: an analysis of the emergency care data set pilot in Oxfordshire from 2012 to 2014. Journal of Epidemiology and Community Health 2017, 71(3), 289-295.
- Piggin J, Pollock A. World Rugby's erroneous and misleading representation of Australian sports' injury statistics. British Journal of Sports Medicine 2017, 51(15), 1108-1108.
- Filippon J, Giovanella L, Konder M, Pollock AM. "Liberalizing" the English National Health Service: background and risks to healthcare entitlement. Cadernos de Saúde Pública 2016, 32(8), e00034716.
- Harrington C, Armstrong H, Halladay M, Havig AK, Jacobsen FF, MacDonald M, Panos J, Pearsall K, Pollock A, Ross L. Comparison of Nursing Home Financial Transparency and Accountability in Four Locations. Ageing International 2016, 41(1), 17-39.
- Kadam AB, Maigetter K, Jeffery R, Mistry NF, Weiss MG, Pollock AM. Correcting India’s chronic shortage of drug inspectors to ensure the production and distribution of safe, high-quality medicines. International Journal of Health Policy and Management 2016, 5(9), 535-542.
- Pollock AM. How marketisation and privatisation is being used to abolish national universal health care systems and what must be done to restore them. Reforma y Democracia 2016, 2016(64), 5-50.
- Ronald LA, McGregor MJ, Harrington C, Pollock A, Lexchin J. Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change?. PLoS Medicine 2016, 13(4), e1001995.
- Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: A systematic analysis (1995-2015). BMC Public Health 2016, 16, 174.
- Pollock AM, Kirkwood G. Removing contact from school rugby will not turn children into couch potatoes. British Journal of Sports Medicine 2016, 50(16), 963-964.
- Leng HMJ, Pollock AM, Sanders D. The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa. South African Medical Journal 2016, 106(4), 350-353.
- Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: A case study of local production in Nepal. Globalization and Health 2015, 11(1), 25.
- Crocker-Buque T, Pollock AM. Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal. Journal of the Royal Society of Medicine 2015, 108(2), 57-67.
- Smith D, Kirkwood G, Pott J, Kourita L, Jessop V, Pollock AM. Childhood injury in Tower Hamlets: Audit of children presenting with injury to an inner city A&E department in London. Injury 2015, 46(6), 1131-1136.
- Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Civil Society Organizations and medicines policy change: A case study of registration, procurement, distribution and use of misoprostol in Uganda. Social Science and Medicine 2015, 130, 242-249.
- Kirkwood G, Parekh N, Ofori-Asenso R, Pollock AM. Concussion in youth rugby union and rugby league: A systematic review. British Journal of Sports Medicine 2015, 49(8), 506-510.
- Pollock A, Roderick P. Duty to care and universal access to health: In defence of a duty to care and provide universal access to health in the face of limited resources. The Medico-legal journal 2015, 83(4), 172-184.
- Pollock AM. Morality and values in support of universal healthcare must be enshrined in law: Comment on “morality and markets in the NHS”. International Journal of Health Policy and Management 2015, 4(6), 399-402.
- Maigetter K, Pollock AM, Kadam A, Ward K, Weiss MG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. International Journal of Health Policy and Management 2015, 4(5), 295-305.
- Leng HMJ, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines. GaBI Journal 2015, 4(2), 58-63.
- Freitag A, Kirkwood G, Pollock AM. Rugby injury surveillance and prevention programmes: Are they effective?. BMJ 2015, 350, h1587.
- Millard C, Brhlikova P, Pollock A. Social networks and health policy: The case of misoprostol and the WHO model essential medicine list. Social Science and Medicine 2015, 132, 190-196.
- Freitag A, Kirkwood G, Scharer S, Ofori-Asenso R, Pollock AM. Systematic review of rugby injuries in children and adolescents under 21 years. British Journal of Sports Medicine 2015, 49(8), 511-519.
- Evans V, Pollock AM. The proliferation of irrational metformin fixed-dose combinations in India. The Lancet Diabetes and Endocrinology 2015, 3(2), 98-101.
- McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock AM. Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs. PLoS Medicine 2015, 12(5), e1001826.
- Pollock AM, Roderick P. Why the Queen's speech on 19 May should include a bill to reinstate the NHS in England. BMJ (Online) 2015, 350, h2257.
- Roderick P, Pollock AM. A wolf in sheep's clothing: How Monitor is using licensing powers to reduce hospital and community services in England under the guise of continuity. BMJ 2014, 349, g5603.
- Millard C, Pollock AM, Brhlikova P. Commentary: Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health. BMJ 2014, 349, g4823.
- Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, Pollock A. The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice 2014, 7(1), 18.
- Steele S, Stuckler D, Mckee M, Pollock AM. The immigration bill: Extending charging regimes and scapegoating the vulnerable will pose risks to public health. Journal of the Royal Society of Medicine 2014, 107(4), 132-133.
- Pollock AM, Roderick P. Trust in the time of markets: Protecting patient information. The Lancet 2014, 383(9928), 1523-1524.
- McCartney M, Goldacre B, Chalmers I, Reynolds C, Mendel J, Smith S, Bewley S, Gordon P, Carroll D, Dean BJ, Greenhalgh T, Heath I, McKee M, Pollock A, Gordon S. Why the GMC should set up a central registry of doctors' competing interests. BMJ 2014, 348, g236.
- Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme. Bulletin of the World Health Organization 2014, 92(7), 482-489.
- Kirkwood G, Hughes TC, Pollock AM. Injury surveillance in Europe and the UK. BMJ 2014, 349, g5337.
- Pollock AM, Price D. Loss of population data sources when health systems are not responsible for geographically defined populations: Implications of the Health and Social Care Act of 2012 in England. Evidence-Based Medicine 2014, 19(1), 4-5.
- McGettigan P, Roderick P, Kadam A, Pollock AM. Threats to antimicrobial resistance control: an ecological study of centrally approved and unapproved formulations sold in India. British Journal of Clinical Pharmacology 2018, Accepted article.
- Pollock AM, Roderick P. Why we should be concerned about accountable care organisations in England’s NHS. BMJ 2018, 30, k343.
- McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. The Lancet Global Health 2017, 5(11), e1075-e1076.
- Kirkwood G, Pollock AM. Patient choice and private provision decreased public provision and increased inequalities in Scotland: a case study of elective hip arthroplasty. Journal of Public Health 2017, 39, 593-600.
- Roderick P, Pollock AM. Authors' reply to Dorsett. BMJ 2014, 349, g6833.
- Steele S, Stuckler D, McKee M, Pollock AM. Authors' response to Shin: We must recognise the actual and opportunity costs of treating immigrants in the National Health Service (NHS). Journal of the Royal Society of Medicine 2014, 107(12), 466-467.
- McGettigan P, Pollock A, Herxheimer A. Department of Health's misguided alert recommending neuraminidase inhibitors for flu. BMJ 2014, 348, g1594.
- Roderick P, Mahajan R, McGettigan P, Pollock AM. India should introduce a new Drugs Act. The Lancet 2014, 383(9913), 203-206.
- Pollock AM, McGettigan P, Roderick P, Jeffery R, Mahajan R. Need for a new drugs bill : commentary. Economic and Political Weekly 2014, 49(33), 15-19.
- Kirkwood G, Pollock AM, Howie C, Wild S. NHS Scotland reduces the postcode lottery for hip arthroplasty: an ecological study of the impact of waiting time initiatives. Journal of the Royal Society of Medicine 2014, 107(6), 237-245.
- White AJ, Batten J, Kirkwood G, Anderson E, Pollock AM. ‘Pre-activity movement control exercise programme to prevent injuries in youth rugby’: some concerns. British Journal of Sports Medicine 2018, epub ahead of print.
- Millard C, Kadam AB, Mahajan R, Pollock AM, Brhlikova P. Availability of brands of six essential medicines in 124 pharmacies in Maharashtra. Journal of Global Health 2018, 8(1), 010402.
- Pollock AM. Portability of budgets and competition for GP practice lists—another back door route to US style ACOs?. London, UK: BMJ Publishing Group, 2018. Available at: http://blogs.bmj.com/bmj/2018/04/17/allyson-pollock-portability-of-budgets-and-competition-for-gp-practice-lists-another-back-door-route-to-us-style-acos/.
- Pollock AM, Price D, Kondilis E, Freitag A, Harding-Edgar L. Planning for closure: The role of special administrators in reducing NHS hospital services in England. BMJ 2013, 347, f7322.
- Pollock AM, Brhlikova P, McGettigan P. Reviewers commentary on Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence. BJOG: An International Journal of Obstetrics and Gynaecology 2013, 120(3), 287-287.
- Pollock AM. Will expansion of the NHS abroad benefit UK patients? No. BMJ 2013, 346, e8496.
- Leonard P, Pollock A. Will expansion of the NHS abroad benefit UK patients? Yes - No. BMJ 2013, 346(7890), e8493.